Subfascial administration of tranexamic acid significantly reduced the need for blood transfusions in older patients undergoing intramedullary nailing for intertrochanteric fractures, according to ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent total knee arthroplasty had a clinically significant reduction in blood loss by 37% at 24 ...

Safety of tranexamic acid (TXA), even at higher doses, was upheld in a meta-analysis. Across 216 randomized trials in various medical disciplines, the incidence of thromboembolic events -- including ...

Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing ...

Research has revealed that many trauma patients have been receiving tranexamic acid without displaying any data-driven indication for the medication, according to an Aug. 17 report from Anesthesiology ...

Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing ...

Included studies. We included 49 studies with a total of 10,591 participants in this meta-analysis. The detailed characteristics of all included studies were listed in Additional file 3 One thing ...

Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration ...

Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in ...

Tranexamic acid is highly efficacious for the treatment of melasma, with optimal outcomes seen through oral administration plus routine topical agents. The efficacy of tranexamic acid alone against ...

Prophylactic tranexamic acid (TXA) during cesarean delivery did not lead to a lower risk of maternal death or blood transfusion, a randomized trial found. Among 11,000 women in 31 U.S. hospitals ...

Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing ...